Proviral Integration Site Moloney Murine Leukemia Virus (PIM) Expression in Urothelial Carcinoma

被引：0
|
作者：
Albertson, D. J.
Bearss, J. J.
Bearss, D. J.
Tripp, S.
Liu, T.
机构：
[1] Univ Utah, Salt Lake City, UT USA
[2] Huntsman Canc Inst, Salt Lake City, UT USA
[3] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
[4] Brigham Young Univ, Provo, UT 84602 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
791
引用
收藏
页码：191A / 192A
页数：2
相关论文
共 50 条
  • [1] Proviral Integration Site Moloney Murine Leukemia Virus (PIM) Expression in Urothelial Carcinoma
    Albertson, D. J.
    Bearss, J. J.
    Bearss, D. J.
    Tripp, S.
    Liu, T.
    LABORATORY INVESTIGATION, 2013, 93 : 191A - 192A
  • [2] Discovery and optimization of aminooxadiazoles as potent proviral integration site of Moloney murine leukemia virus kinases (Pim) inhibitors
    Wurz, Ryan P.
    Pettus, Liping
    Jackson, Claire
    Wu, Bin
    Wang, Hui-Ling
    Herberich, Bradley
    Cee, Victor
    Lanman, Brian
    Reed, Tony
    Chavez, Frank, Jr.
    Nixey, Thomas
    Laszlo, Jimmy, III
    Wang, Paul
    Sastri, Christine
    Guerrero, Nadia
    Winston, Jeff
    Lipford, Rusty
    Lee, Matthew R.
    Andrews, Kristin
    Mohr, Christopher
    Xu, Yang
    Zhou, Yihong
    Reid, Darren
    Tasker, Andrew S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [3] Proviral Integration Site for Moloney Murine Leukemia Virus (PIM) Kinases Promote Human T Helper 1 Cell Differentiation
    Tahvanainen, Johanna
    Kylaniemi, Minna K.
    Kanduri, Kartiek
    Gupta, Bhawna
    Lahteenmaki, Hanna
    Kallonen, Teemu
    Rajavuori, Anna
    Rasool, Omid
    Koskinen, Paivi J.
    Rao, Kanury V. S.
    Lahdesmaki, Harri
    Lahesmaa, Riitta
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (05) : 3048 - 3058
  • [4] An analysis of proviral insertion site of Moloney murine leukemia virus, PIM1, kinase expression and clinical outcomes in renal cell carcinoma
    Holder, Sheldon L.
    Lagos, Galina
    Carneiro, Benedito A.
    Mega, Anthony
    De Souza, Andre
    Mckay, Rana R.
    Elliott, Andrew
    Nabhan, Chadi
    Graff, Stephanie L.
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Expression of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (Pim-1) Is Post-transcriptionally Regulated by Tristetraprolin in Cancer Cells
    Kim, Hong Kyeung
    Kim, Chae Won
    Vo, Mai-Tram
    Lee, Hyun Hee
    Lee, Ji Young
    Yoon, Nal Ae
    Lee, Chae Yeong
    Moon, Chang Hoon
    Min, Young Joo
    Park, Jeong Woo
    Cho, Wha Ja
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (34) : 28770 - 28778
  • [6] Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes
    Choi, Yong Seok
    Ha, You Jung
    Hur, Jaehyung
    Kang, Eun Ha
    Song, Yeong Wook
    Lee, Yun Jong
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in Moloney murine leukemia virus (PIM-1) kinase
    Bullock, AN
    Debreczeni, JÉ
    Fedorov, OY
    Nelson, A
    Marsden, BD
    Knapp, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) : 7604 - 7614
  • [8] Proviral Integration of Moloney Virus-2 (PIM-2) Expression Level as a Prognostic Marker in Patients with Acute Myeloid Leukemia
    Hamed, Gehad
    Omar, Hisham M.
    Sarhan, Abbas M.
    Salah, Hossam E.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 4247 - 4258
  • [9] Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) inhibition with AZD1208 to prevent resistance to osimertinib in EGFR mutant NSCLC
    Bracht, J.
    Karachaliou, N.
    Berenguer, J.
    Attili, I.
    Ito, M.
    Codony-Servat, C.
    Codony-Servat, J.
    Filipska, M.
    Gil, N.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S13 - S13
  • [10] MUTANTS AND PSEUDOREVERTANTS OF MOLONEY MURINE LEUKEMIA-VIRUS WITH ALTERATIONS AT THE INTEGRATION SITE
    COLICELLI, J
    GOFF, SP
    CELL, 1985, 42 (02) : 573 - 580
12345